Why the study?
Does the combination of HOMA with A/L ratio predict the severity of liver damage in patients with NAFLD?
Does the combination of HOMA with A/L ratio predict the severity of liver damage in patients with NAFLD?
The combination of HOMA and A/L ratio offers a potential non-invasive method to assess liver damage severity in patients with NAFLD.
Does not support routine NAFLD staging changes; leaves open need for prospective validation of this biomarker approach.
This study shows that in patients with NAFLD, the combination of HOMA with A/L ratio may be a useful non-invasive approach to appreciate the severity of liver damage.
No takes yet. Share an insight, caveat, or question.
Lemoine et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: